Comparative Pharmacology
Head-to-head clinical analysis: PENICILLIN G POTASSIUM IN PLASTIC CONTAINER versus PIPRACIL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PENICILLIN G POTASSIUM IN PLASTIC CONTAINER versus PIPRACIL.
PENICILLIN G POTASSIUM IN PLASTIC CONTAINER vs PIPRACIL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation and activating autolytic enzymes.
Piperacillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), interfering with peptidoglycan cross-linking during cell wall assembly.
2-4 million units IV every 4 hours for moderate to severe infections; up to 24 million units/day for serious infections (meningitis, endocarditis).
3.375 g IV every 6 hours (piperacillin 3 g + tazobactam 0.375 g) over 30 minutes; for nosocomial pneumonia: 4.5 g IV every 6 hours over 30 minutes.
None Documented
None Documented
0.5–1 hour (normal renal function). Prolonged in renal impairment (up to 7–10 hours in anuria).
0.7-1.2 hours in adults with normal renal function; prolonged to 3-6 hours in renal impairment (CrCl <20 mL/min). In neonates, half-life is 3-4 hours.
Renal: 60–90% unchanged via tubular secretion and glomerular filtration. Biliary/fecal: <10%.
Primarily renal (tubular secretion and glomerular filtration) as unchanged drug (50-70%); biliary/fecal excretion is a minor route (approximately 10-20% as unchanged drug and metabolites).
Category A/B
Category C
Penicillin Antibiotic
Penicillin Antibiotic